Sheth; Kamlesh

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sheth; Kamlesh.The latest application filed is for "highly purified batches of pharmaceutical grade 1-deoxygalactonojirimycin compounds".

Company Profile

0.13.17

Sheth; Kamlesh - North Brunswick NJ
Sheth; Kamlesh - Cranbury NJ US
Sheth; Kamlesh - Suwanee GA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Highly Purified Batches Of Pharmaceutical Grade 1-deoxygalactonojirimycin Compounds App 20220194899 - Sheth; Kamlesh ; et al.	2022-06-23
Highly Purified Batches Of Pharmaceutical Grade Migalastat And Methods Of Producing The Same App 20220185776 - Sheth; Kamlesh ; et al.	2022-06-16
Compounds for preventing and/or treating lysosomal storage disorders and/or degenerative disorders of the central nervous system Grant 10,224,333 - Boyd , et al.	2019-03-05
Method For The Treatment Of Pompe Disease Using 1-deoxynojirimycin Derivatives App 20180221357 - MUGRAGE; Benjamin ; et al.	2018-08-09
Novel Compounds For Preventing And/Or Treating Lysosomal Storage Disorders And/Or Degenerative Disorders Of The Central Nervous System App 20170365609 - Boyd; Robert ; et al.	2017-12-21
Compounds for preventing and/or treating lysosomal storage disorders and/or degenerative disorders of the central nervous system Grant 9,750,733 - Boyd , et al. September 5, 2	2017-09-05
New Method for Preparing Isofagomine and Its Derivatives App 20170044102 - Rybczynski; Philip J. ; et al.	2017-02-16
Novel Compounds For Preventing And/Or Treating Lysosomal Storage Disorders And/Or Degenerative Disorders Of The Central Nervous System App 20170020853 - Boyd; Robert ; et al.	2017-01-26
Method for preparing isofagomine and its derivatives Grant 9,481,700 - Rybczynski , et al. November 1, 2	2016-11-01
Compounds for preventing and/or treating lysosomal storage disorders and/or degenerative disorders of the central nervous system Grant 9,464,050 - Boyd , et al. October 11, 2	2016-10-11
Method for the Treatment of Pompe Disease Using 1-Deoxynojirimycin Derivatives App 20160051528 - Mugrage; Benjamin ; et al.	2016-02-25
Method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives Grant 9,181,184 - Mugrage , et al. November 10, 2	2015-11-10
Polyurea Coatings Containing Silane App 20150072154 - Sheth; Kamlesh ; et al.	2015-03-12
Novel Compounds For Preventing And/Or Treating Lysosomal Storage Disorders And/Or Degenerative Disorders Of The Central Nervous System App 20150050263 - Boyd; Robert ; et al.	2015-02-19
Polyurea coatings containing silane Grant 8,889,259 - Sheth , et al. November 18, 2	2014-11-18
One-component epoxy coating compositions Grant 8,871,888 - Mowrer , et al. October 28, 2	2014-10-28
New Method For Preparing Isofagomine And Its Derivatives App 20140005372 - Rybczynski; Philip ; et al.	2014-01-02
Method for preparing isofagomine and its derivatives Grant 8,487,110 - Rybczynski , et al. July 16, 2	2013-07-16
Polyurea Coatings Containing Silane App 20130004777 - Sheth; Kamlesh ; et al.	2013-01-03
One-Component Epoxy Coating Compositions App 20100297357 - Mowrer; Norman R. ; et al.	2010-11-25
Hydroxy Piperidine Derivatives To Treat Gaucher Disease App 20100189708 - Fan; Jian-Qiang ; et al.	2010-07-29
New Method For Preparing Isofagomine And Its Derivatives App 20100160638 - Rybczynski; Philip ; et al.	2010-06-24
Hydroxy piperidine derivatives to treat gaucher disease Grant 7,741,340 - Fan , et al. June 22, 2	2010-06-22
Method for the treatment of Pompe disease using 1-deoxynojirimycin and derivatives App 20060264467 - Mugrage; Benjamin ; et al.	2006-11-23
Glucoimidazole and polyhydroxycyclohexenyl amine derivatives to treat gaucher disease App 20050137223 - Fan, Jian-Qiang ; et al.	2005-06-23
Hydroxy piperidine derivatives to treat gaucher disease App 20050130972 - Fan, Jian-Qiang ; et al.	2005-06-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.